Table 1.
Clinical characteristics of the patients.
| Confirmed COVID-19, 77 cases (71%) | Non-COVID-19, 32 cases (29%) | Total 109 cases (%) | P value | |
|---|---|---|---|---|
| Median age (IQR) (years) | 53 (82–36) | 68 (25–80) | — | — |
|
| ||||
| Male sex no. (%) | 64 (83) | 16 (50) | 80 (73) | 0.005 |
|
| ||||
| Medical history no. (%) | ||||
| IHD | 9 (11) | 20 (66) | 19 (20) | <0.0001 |
| CABC | 2 (2.6) | 25 (53) | 10 (10) | 0.001 |
| Hypertension | 20 (25) | 12 (80) | 32 (34) | 0.002 |
| Diabetes mellitus | 25 (32) | 30 (100) | 39 (42) | <0.0001 |
| CVA | 8 (1) | 2 | — | 0.3 |
| COPD | 3 (3) | 3 (20) | 2 (2) | 0.02 |
| Chronic renal impairment | 25 (32) | 22 (66) | 10 (66) | 0.001 |
| Hemodialysis | 6 (0.7) | 9 (25) | — | 0.01 |
| Cancer | 0 | 1 (6) | 1 (1) | 0.091 |
|
| ||||
| Status on admission to ICU no. (%) | ||||
| Acute MI | 2 (2.6) | 20 (10) | 12 (13) | 0.001 |
| Acute PE | 9 (11.6) | 0 | — | 0.038 |
| Acute CVA | 6 | 0 | — | 0.117 |
| Symptom duration (median, days) | 5 (2–10) | 2 (3–4) | — | — |
| Hypoxemia | All | All | 109 (100%) | 0.02 |
| PO2/FiO2 (mean) | 145 | 226 | — | 0.026 |
| HFNC | 35 (71) | 2 (33%) | 50 (64%) | 0.002 |
| IV | 21 (27) | 7 (26%) | 25 (27%) | — |
| Facemask | 17 (22) | 2 (13%) | 19 (20%) | — |
| SOFA score (mean) | 7.7 | 6 | — | 0.39 |
| RT-PCR positive (%) | 75 (97.4) | 0 | — | — |
| RT-PCR negative (%) | 2 (2) | 32 (100) | — | — |
|
| ||||
| US chest finding | ||||
| Aeration score (mean) | 27 ± 9 | 21 ± 6.5 | 0.018 | — |
| SPC score (mean) | 13 ± 10.7 | 1 ± 0.258 | <0.0001 | — |
Plus-minus values are means ± SD; IHD, ischemic heart disease; HFNC, high-flow nasal cannula; IV, invasive ventilation; COPD, chronic obstructive pulmonary disease; SPC, subpleural consolidation.